WallStSmart

Accenture plc (ACN)vsIBEX Ltd (IBEX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Accenture plc generates 11560% more annual revenue ($73.10B vs $626.95M). ACN leads profitability with a 10.7% profit margin vs 7.5%. IBEX trades at a lower P/E of 11.9x. ACN earns a higher WallStSmart Score of 66/100 (B-).

ACN

Strong Buy

66

out of 100

Grade: B-

Growth: 5.3Profit: 7.5Value: 6.7Quality: 6.5
Piotroski: 3/9Altman Z: 2.79

IBEX

Buy

59

out of 100

Grade: C

Growth: 6.7Profit: 7.0Value: 6.7Quality: 7.5
Piotroski: 5/9Altman Z: 3.62
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACNUndervalued (+7.7%)

Margin of Safety

+7.7%

Fair Value

$199.33

Current Price

$183.90

$15.43 discount

UndervaluedFair: $199.33Overvalued

Intrinsic value data unavailable for IBEX.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACN5 strengths · Avg: 8.6/10
Market CapQuality
$112.54B9/10

Large-cap with strong market position

Return on EquityProfitability
24.5%9/10

Every $100 of equity generates 25 in profit

Debt/EquityHealth
0.269/10

Conservative balance sheet, low leverage

P/E RatioValuation
14.7x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$3.60B8/10

Generating 3.6B in free cash flow

IBEX5 strengths · Avg: 9.0/10
P/E RatioValuation
11.9x10/10

Attractively priced relative to earnings

Altman Z-ScoreHealth
3.6210/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
29.3%9/10

Every $100 of equity generates 29 in profit

Revenue GrowthGrowth
16.8%8/10

16.8% revenue growth

EPS GrowthGrowth
21.9%8/10

Earnings expanding 21.9% YoY

Areas to Watch

ACN1 concerns · Avg: 3.0/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

IBEX2 concerns · Avg: 3.0/10
Market CapQuality
$521.37M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
7.5%3/10

7.5% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : ACN

The strongest argument for ACN centers on Market Cap, Return on Equity, Debt/Equity. PEG of 1.29 suggests the stock is reasonably priced for its growth.

Bull Case : IBEX

The strongest argument for IBEX centers on P/E Ratio, Altman Z-Score, Return on Equity. Revenue growth of 16.8% demonstrates continued momentum.

Bear Case : ACN

The primary concerns for ACN are Piotroski F-Score.

Bear Case : IBEX

The primary concerns for IBEX are Market Cap, Profit Margin.

Key Dynamics to Monitor

ACN profiles as a value stock while IBEX is a growth play — different risk/reward profiles.

ACN carries more volatility with a beta of 1.09 — expect wider price swings.

IBEX is growing revenue faster at 16.8% — sustainability is the question.

ACN generates stronger free cash flow (3.6B), providing more financial flexibility.

Bottom Line

ACN scores higher overall (66/100 vs 59/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Accenture plc

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Accenture plc is an Irish-domiciled multinational company that provides consulting and processing services. It has been incorporated in Dublin, Ireland since 2009.

IBEX Ltd

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

IBEX Limited provides comprehensive technology-enabled customer lifecycle experience solutions in the United States and internationally.

Visit Website →

Want to dig deeper into these stocks?